Navigation Links
XTL Biopharmaceuticals Announces Appointment of David Grossman and Boaz Shweiger to Board of Directors
Date:2/11/2009

VALLEY COTTAGE, N.Y., Feb. 11 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB; TASE: XTL) today announced that Mr. David Grossman and Mr. Boaz Shweiger have been appointed to XTL's Board of Directors, effective today. In addition, Mr. Grossman will also be assuming the role of Co-Chief Executive Officer, with no remuneration, to assist in XTL's analysis of its strategic alternatives.

Ron Bentsur, Co-Chief Executive Officer of XTL, commented, "We decided to make these appointments at this time in order to ensure management continuity and a more effective transition in the event that at the upcoming March 11 shareholders' meeting, the proposed slate of directors are elected."

Mr. Grossman, 34, served as a Vice President of Eurocom Investments LP, a private equity fund focused on long-term investments mainly in Israeli public companies, from March 2006 to December 2008. Also from March 2006 to December 2008, Mr. Grossman was Vice President of Sahar Investments Ltd, (TASE: SAIN) which focused on investments in the Life Sciences arena. From July 2003 to March 2006, Mr. Grossman was a Senior Analyst at Israel Health Care Ventures, an Israeli healthcare venture capital fund. From 2001 to March 2003, Mr. Grossman was a senior investment banker with Reliance Capital Ltd. From 2001- 2003, he was a partner of Magna Business Development, a consulting boutique. In addition, Mr. Grossman is currently a director and member of the audit committee of Bio Light Israeli Life Science Investments Ltd. (TASE: BOLT) since December 2008, and from May 2007 to July 2008 was a Director and member of the audit committee of Gilat Satcom Ltd. (AIM: GLT). Mr. Grossman received a BA business administration with a focus on information technology, from the Interdisciplinary Center Herzliya.

Mr. Shweiger, 33,
'/>"/>

SOURCE XTL Biopharmaceuticals Ltd.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Corrected: XTL Biopharmaceuticals to Convene Extraordinary Shareholders Meetings after Receipt of Shareholder Letter
2. XTL Biopharmaceuticals to Convene Extraordinary Shareholders Meetings after Receipt of Shareholder Letter
3. XTL Biopharmaceuticals Announces Receipt of NASDAQ Notice of Delisting
4. XTL Biopharmaceuticals Provides Update on Potential Strategic Alternatives
5. Keryx Biopharmaceuticals to Present at the J.P. Morgan 27th Annual Healthcare Conference
6. Johnson & Johnson Completes Acquisition of Omrix Biopharmaceuticals, Inc.
7. XTL Biopharmaceuticals Implements Restructuring Plan
8. Nventa Biopharmaceuticals Announces Third Quarter 2008 Financial Results and Recent Corporate Highlights
9. Morria Biopharmaceuticals Plc Announces Positive Clinical Results for MRX-4 in its Phase II Clinical Study in Allergic Rhinitis Patients
10. Morria Biopharmaceuticals Plc to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
11. Keryx Biopharmaceuticals Notified that Nasdaq Has Extended Minimum Bid Price Rule Compliance Period
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... (PRWEB) May 20, 2013 Kitware, a ... visualization tool that enables the exploration of hospital ... created in response to the recent release of “Medicare ... the top 100 most-billed procedures from the Centers for ... costs for similar procedures at hospitals across the country ...
(Date:5/20/2013)... 2013 In Early 2013, Dr. ... biotoxin related illnesses , announced his vision for creating ... advance his protocol for treating Chronic Inflammatory Response Syndrome ... physician to achieve certification in the Shoemaker Protocol. ... practice the Shoemaker Protocol in other parts of the ...
(Date:5/20/2013)... The World Molecular Imaging Society (WMIS) Board ... as Executive Director. Baird will assume leadership of ... WMIS vision is to encompass and promote preclinical and ... diseases in the developed and developing world. The ... by integrating the Academy of Molecular Imaging and the ...
(Date:5/19/2013)... New York, NY (PRWEB) May 19, 2013 ... largest solar boat, today announced a new speed record ... Having left from Las Palmas, Spain, on April 25, ... across the Atlantic Ocean at the average speed of ... French West Indies on May 18, 2013. The first-of-its-kind ...
Breaking Biology Technology:Kitware Enables Interactive Exploration of CMS Medicare Data 2Dr. Ritchie Shoemaker Certifies Third Physician in His Treatment Protocol for Chronic Inflammatory Response Syndrome (CIRS) 2WMIS Appoints Lisa Baird as Next Executive Director 2MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 2MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 3MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 4MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 5MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 6
... International, Inc. (OTC Bulletin Board: YGYB; "Yongye" or the ... products located in the People,s Republic of China, today ... retail stores in its sales network set a new ... in Qianjiang City in Hubei Province sold 15,310 bottles ...
... Sinovac Biotech Ltd. (NYSE Amex: SVA ), ... announced that it has filed its Annual Report on Form ... year ended December 31, 2008 on May 1, 2009. ... the Company,s website under the investor relations section at: ...
... BONITA SPRINGS, Fla., May 1 Tigris Pharmaceuticals, Inc., ... dosing has started in a Phase I clinical trial ... of geranylgeranyltransferase I (GGTase I) that induces apoptosis by ... I study is led by Dr. Peter O,Dwyer, Professor ...
Cached Biology Technology:Yongye Biotechnology Distributor has Record Breaking Single Store Sales Day 2Yongye Biotechnology Distributor has Record Breaking Single Store Sales Day 3Sinovac Biotech Ltd. Files Annual Report on Form 20-F 2First Patient Dosed in Phase I Clinical Trial of Tigris Pharmaceuticals' GGTI-2418 2First Patient Dosed in Phase I Clinical Trial of Tigris Pharmaceuticals' GGTI-2418 3
(Date:5/16/2013)... our pulses outside of the gym. But doctors use the ... , Zhenan Bao, a professor of chemical engineering at Stanford, ... and no wider than a postage stamp. The flexible skin-like ... sensitive enough to help doctors detect stiff arteries and cardiovascular ... continuously track heart health and provide doctors a safer method ...
(Date:5/16/2013)... , May 16, 2013 The ... Award on Tuesday to Germany,s ... biometric border control system. DERMALOG has been ... Best Practices Award in the category Global Biometrics and ... edge Biometric   Border Control System . One ...
(Date:5/15/2013)... "keystone" molecules that have powerful behavioral effects on ... in structuring ecosystems, according to a theory proposed ... The authors of the theory, Ryan P. Ferrer ... of the University of California at Los Angeles, ... plants that may be uncommon but exert a ...
Breaking Biology News(10 mins):Stanford engineers monitor heart health using paper-thin flexible 'skin' 2Stanford engineers monitor heart health using paper-thin flexible 'skin' 3Global Biometrics and Border Control Award for DERMALOG 2Global Biometrics and Border Control Award for DERMALOG 3Global Biometrics and Border Control Award for DERMALOG 4Natural 'keystone molecules' punch over their weight in ecosystems 2
... claims advising breastfeeding moms that alcoholic beverages can improve ... Center report that even moderate doses of alcohol affect ... , "This information is important for women," comments lead ... is drinking alcohol just to improve the quality or ...
... for the first time that human eggs may develop ... from adult human ovaries. Oocytes derived from the culture ... suitable for fertilization and development into an embryo. These ... Biology and Endocrinology, offer important new strategies for use ...
... St. Louis have learned that a temporal "window of ... diabetic rats with embryonic pig tissues. , In those ... that they didn't have to give anti-rejection drugs to ... had expected rats that received no immune suppression would ...
Cached Biology News:Alcohol consumption disrupts breastfeeding hormones 2Alcohol consumption disrupts breastfeeding hormones 3Human Eggs Can Develop From Ovarian Surface Cells In Vitro 2Precise Timing Enabled Pig-to-rat Transplants To Cure Diabetes 2Precise Timing Enabled Pig-to-rat Transplants To Cure Diabetes 3
... Immunogen KLH-conjugated, synthetic ... 47-66 (PAEV-GPGAVGERTPRKKEPP) of human BRAF-HDAC ... (BHC110/LSD1). Quality Assurance ... Stability 2 years ...
Adducin beta (C-16)...
Geneticin Selective Antibiotic liquid...
...
Biology Products: